ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis

Nom du journal : Clin Cancer Res

Année : 2011

Volume : 17

Page de départ : 1632

Page de fin : 1640

Auteurs: Yin M, Yan J, Abad A, Voutsina A, Tibaldi C, Christiani DC, Graziano F, Liu G, Lenz HJ, Chew HK, Yu H, Kim HJ, Steffensen K, Robert J, Hayashi K, Rosell R, Booton R, Im SA, Wang WS, Wei QO, Trocoli A,